Evidence map›Paper›PMID 34334250›Full record

ReviewTrends in pharmacological sciences2021

In vivo functions of p75

Subash C Malik, Elif G Sozmen, Bernat Baeza-Raja, Natacha Le Moan, Katerina Akassoglou, Christian Schachtrup

Open access · greenAbstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. ERCC1/NGFR affects prognosis in basal-like breast cancer.European journal of medical research · 2025
    Article
  10. Review
  11. Article
  12. Bladder p75Life (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Subash C MalikInstitute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany.
Elif G SozmenCenter for Neurovascular Brain Immunology at Gladstone and UCSF; Gladstone Institutes, San Francisco, CA, USA; Department of Neurology and Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Bernat Baeza-RajaGladstone Institutes, San Francisco, CA, USA.
Natacha Le MoanGladstone Institutes, San Francisco, CA, USA.
Katerina AkassoglouCenter for Neurovascular Brain Immunology at Gladstone and UCSF; Gladstone Institutes, San Francisco, CA, USA; Department of Neurology and Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Christian SchachtrupInstitute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Basics in NeuroModulation (NeuroModul Basics), Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: christian.schachtrup@anat.uni-freiburg.de.
Gladstone Institutes · USUniversity of California, San Francisco · USUniversity of Freiburg · DE

Funding

Neurovascular Interactions: Mechanisms, imaging, therapeutic potentialR35NS097976 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI AKASSOGLOU, KATERINA · 2016 to 2023
$11.1M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Fibrinogen and vascular cognitive impairment: mechanisms, imaging, therapeuticsRF1AG064926 · NIA · J. DAVID GLADSTONE INSTITUTES · PI AKASSOGLOU, KATERINA, ELLISMAN, MARK H · 2019 to 2019
$4.5M
NIAID NIH HHS T32 AI007334NIA NIH HHS RF1 AG064926NINDS NIH HHS R35 NS097976
6 · The paper itself

Abstract

The p75 neurotrophin receptor (p75

Indexed as

Alzheimer DiseaseReceptor, Nerve Growth FactorCell DeathHumansReceptor, Nerve Growth FactorAlzheimer’s diseasefibrinolysisneurodegenerative diseasesneurotrophin receptorssmall molecule inhibitors

Identifiers

PMID34334250
PMCPMC8502531
OpenAlexW3185099040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.